Physicians Financial Services Inc. Decreases Holdings in The Clorox Company (NYSE:CLX)

Physicians Financial Services Inc. trimmed its position in shares of The Clorox Company (NYSE:CLX) by 7.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,155 shares of the company’s stock after selling 400 shares during the period. Physicians Financial Services Inc.’s holdings in Clorox were worth $837,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Brooklyn Investment Group raised its holdings in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares during the period. Prospera Private Wealth LLC bought a new position in Clorox in the 3rd quarter valued at $27,000. Continuum Advisory LLC increased its stake in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Asset Planning Inc bought a new stake in shares of Clorox during the fourth quarter worth $32,000. Finally, Catalyst Capital Advisors LLC purchased a new stake in shares of Clorox during the third quarter valued at $54,000. Institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

CLX has been the subject of a number of research analyst reports. DA Davidson decreased their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. JPMorgan Chase & Co. increased their price target on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $158.21.

Clorox Stock Performance

NYSE CLX opened at $152.93 on Friday. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The stock has a market cap of $18.84 billion, a price-to-earnings ratio of 41.78, a price-to-earnings-growth ratio of 2.54 and a beta of 0.42. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The business has a fifty day moving average of $158.11 and a 200-day moving average of $159.68.

Clorox (NYSE:CLX) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the business posted $2.16 EPS. As a group, analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.